PHCCC
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
PHCCC is a research drug which acts as a glutamate receptor ligand, particularly being a positive allosteric modulator at the mGluR 4 subtype, as well as an agonist at mGluR 6 . It has anxiolytic effects in animal studies. PHCCC and similar drugs have been suggested as novel treatments for Parkinson's disease.
PHCCC is a research drug which acts as a glutamate receptor ligand, particularly being a positive allosteric modulator at the mGluR 4 subtype, as well as an agonist at mGluR 6 . It has anxiolytic effects in animal studies. PHCCC and similar drugs have been suggested as novel treatments for Parkinson's disease. ==See also== CPCCOEt ==References==
Text derived from https://en.wikipedia.org/w/index.php?oldid=1361888522 under CC BY-SA 4.0; modifications have been made.